Posted: October 13th, 2020
General Assembly and Annual Congress – 4 December In the light of the ongoing pandemic, the EPLAW Board has taken the difficult decision not to hold an in-person General Assembly and Annual Congress this year. Instead, the General Assembly and Annual Conference will be held online in a closed virtual space. The online meeting will […]
READ MORE
Posted: October 8th, 2020
Yesterday, EPLAW held its first member driven knowledge webinar. The session lasted one hour and centred around a panel discussion of recent learnings from remote hearings in a number of jurisdictions. Approximately fourty EPLAW members participated. Moderator Myles Jelf guided panelists Tess Waldron, Kristof Neefs, Tilman Müller-Stoy, Fabrizio Jacobacci and Mike Gilbert through various topics […]
READ MORE
Posted: October 5th, 2020
Nokia v. Daimler, District Court of Mannheim, dec. of August 18, 2020, case docket 2 O 34/19 On August 18, 2020, the District Court of Mannheim handed down the first judgment in the current litigation campaign of Nokia v. Daimler. Despite Daimler’s FRAND defense, the Court enjoined Daimler from using a certain technology in Daimler […]
READ MORE
Posted: October 2nd, 2020
Lacosamide / Commercial Court no. 5 of Barcelona, 14 April 2020, Docket No. 672/2017 / Invalidity action (public availability of a prior art document) & action for threat of patent infringement On 8 September 2017 the plaintiff, LABORATORIOS NORMON, S.A. (hereinafter, “NORMON”) filed an invalidity action against the companies RESEARCH CORPORATION TECHNOLOGIES INC., UCB BIOPHARMA […]
READ MORE
Posted: September 26th, 2020
Eli Lilly and Company and Lilly France v. Fresenius Kabi France and Fresenius Kabi Groupe France, Judiciary Court of Paris, France, 11 September 2020, Docket № 17/10421, by Pierre Véron, Honorary President, EPLAW Joining a majority of European Courts, the Paris court has held that Eli Lilly’s patent, claiming the combined administration of pemetrexed disodium […]
READ MORE
Posted: September 25th, 2020
Patent Holder v. Soluciones Bioregenerativas, S.L, Commercial Court No. 4 of Barcelona, Spain, 9 September 2019, Case number 128/2018 In a decision dated 9 September 2019, the Commercial Court No. 4 of Barcelona made an interesting analysis in a case of contributory patent infringement, providing useful insights into the assessment of the various elements specific […]
READ MORE
Posted: September 25th, 2020
Traditionally, before the Paris first instance court (tribunal judiciaire), the validity and infringement of a patent and, more rarely, the compensation for damages are addressed, pleaded and judged together. However, sometimes, the particular context of a dispute leads the judge in charge of case preparation to dissociate these issues, in order to rule on them […]
READ MORE
Posted: September 24th, 2020
CDVI v. Impro, Court of Appeal of The Hague, the Netherlands, 23 June 2020, ECLI:NL:GHDHA:2020:1622 Facts Construction Diffusion Vente Internationale SA (“CDVI”) is a global supplier of access systems and electronic locks. Access & Beyond B.V., formerly Impro Technologies Europe B.V. (“Impro”), is a distributor of Impro branded products such as security equipment and systems […]
READ MORE
Posted: September 14th, 2020
The recent decision “Divisional Game” of the Munich District Court I, dated 24 February 2020 (docket no. 7 O 1456/20) is a landmark decision. This decision was handed down in ex-parte preliminary injunction proceedings and was based on an undue obstruction of competitors pursuant to German Unfair Competition Law. The bottom line of this decision […]
READ MORE
Posted: September 10th, 2020
Joined cases: Biogen B.V. and Samsung Bioepis UK Limited v. Richter Gedeon NYRT and Richter Gedeon NYRT v. Biogen Netherlands B.V. and Samsung Bioepis B.V., District Court The Hague, 29 July 2020, ECLI:NL:RBDHA:2020:7089 Richter is the holder of EP 3 212 667 B1 (“EP 667”) which claims a pharmaceutical formulation which is free of a […]
READ MORE
EMAIL US
